Business Context and Reporting Period
This Form 8-K Current Report was filed by Clarivate Analytics Plc on April 10, 2020. The filing primarily addresses corporate governance changes, specifically the departure of a director and the commencement of the distribution of materials for the 2020 Annual General Meeting (AGM) scheduled for May 7, 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate events rather than financial performance data.
Material Changes
- Director Departure: Matthew Scattarella informed the Company of his decision to step down from the Board of Directors effective as of the AGM on May 7, 2020. He had served as a Class II director since May 2019.
- Board Nominations: The Board nominated Jane Okun Bomba and Richard W. Roedel to stand for election as directors.
- Non-Contesting Directors: Sir Martin Broughton, Charles E. Moran, and Amir Motamedi, who have served since May 2019, are not standing for re-election at the AGM.
Outlook, Risks, and Contingencies
- COVID-19 Impact on AGM: The Company is actively monitoring the evolving COVID-19 coronavirus situation regarding public health and travel concerns. It reserves the right to change the logistics of the Annual General Meeting if necessary to protect the health and well-being of shareholders and employees. Any changes will be communicated via press release and a subsequent Form 8-K.
- Regulatory Disclosure: Information regarding the AGM and director nominations is furnished under Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, except as expressly stated.
Key Facts for Investor Verification
- Verify the final composition of the Board of Directors following the May 7, 2020, Annual General Meeting.
- Monitor for any future 8-K filings regarding changes to the AGM format or location due to the COVID-19 pandemic.
- Review the full Proxy Statement (Exhibit 99.1) for detailed biographical information on the new director nominees and the rationale for the departing directors.